Sanofi Announces Dupixent® (Dupilumab) Shows Positive Topline Results In Two Phase 3 Trials Of Patients With Chronic Rhinosinusitis With Nasal Polyps 글 내용 전체보기
Tentative FDA Approval For Generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg Received By Lupin 글 내용 전체보기
Sale Of Its API Manufacturing Business Unit In Jeedimetla, Hyderabad Announced By Dr. Reddy’s Laboratories 글 내용 전체보기
Tentative Approval From The USFDA For Linagliptin And Metformin Hydrochloride Tablets Received By Zydus 글 내용 전체보기
